Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

50.80
Delayed Data
As of Jul 24
 -0.04 / -0.08%
Today’s Change
37.38
Today|||52-Week Range
51.13
+32.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line2.6B2.3B4.4B1.4B
 
 
 
 
 
Depreciation1.7B1.5B1.5B1.4B
 
 
 
 
 
Total Other Cash Flow266.0M333.0M-2.8B2.0B
 
 
 
 
 
Funds From Operations4.6B4.2B3.1B4.7B
 
 
 
 
 
Extraordinary Items0.000.000.00-25.0M
 
 
Funds From/For Other Operating Expenses1.2B490.0M156.0M1.5B
 
 
 
 
 
Net Cash Flow - Operating Activities3.3B3.7B3.0B3.2B
 
 
 
 
 
 
InvestingIncrease In Investments-10.1B-1.5B-4.9B-2.8B
 
 
 
 
 
Decrease In Investments7.8B5.6B6.4B3.7B
 
 
 
 
 
Capital Expenditures-1.1B-1.1B-1.1B-1.1B
 
 
 
 
 
Fixed Asset Disposal----230.0M25.0M
 
 
 
Net Assets From Acquisitions -580.0M-3.3B-235.0M-80.0M
 
 
 
 
 
Other Investing - Sources21.0M75.0M52.0M42.0M
 
 
 
 
 
Net Cash Flow Investing-3.9B-202.0M406.0M-248.0M
 
 
 
 
 
 
FinancingShort Term Borrowings2.1B1.3B-1.3B-1.8B
 
 
 
 
 
Long Term Borrowings9.0M0.002.5B14.9B
 
 
 
 
Long Term Debt Reduction-303.0M-577.0M-57.0M-12.0M
 
 
 
 
 
Net Proceeds Stock Sale395.0M429.0M314.0M248.0M
 
 
 
 
 
Common Preferred Redeemed-1.6B-2.2B-2.2B-522.0M
 
 
 
 
 
Common Dividends-882.0M-1.3B-1.4B-1.5B
 
 
 
 
 
Cash Dividends Paid - Total-882.0M-1.3B-1.4B-1.5B
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing6.4B400.0M17.0M195.0M
 
 
 
 
 
Net Cash Flow - Financing-6.7B-2.7B-2.2B11.1B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-26.0M-143.0M-198.0M-483.0M
 
 
 
 
 
 
Net Change In Cash-7.3B731.0M1.1B14.1B